Skip to content
YCS22· AI

InVision Medical Technology

AI Diagnosis of Heart Disease

ActiveChecked 24h ago
Batch
S22
Status, per YC
Active
Team size
2
HQ
San Francisco, CA
In S22233 companies, 55% AI
invisionmedtech.comYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About InVision Medical Technology

At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.

San Francisco, CA, USA

InVision Medical Technology: questions

Which YC batch was InVision Medical Technology in?

InVision Medical Technology was in Y Combinator's Summer 2022 batch (S22).

Is InVision Medical Technology still active?

Y Combinator lists InVision Medical Technology as active.

Where is InVision Medical Technology based?

InVision Medical Technology lists San Francisco, CA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.